Overview

Unit drug dose delivery system market is poised to register a CAGR of over 5% during the forecast period of 2022 to 2028. 

Hospitals and clinics use unit drug dose delivery systems for accurate dosing, owing to the ease of storage, accurate dosing, and ease of disposal they allow. The driving force for the unit drug dose delivery systems globally is the rise in demand for prefilled syringes among patient population. With pharmaceuticalsand healthcare industries growing at a higher rate. This market is expected to experience huge growth in the near future. Key market players are expanding their production capabilities and also enhancing their global reach to cementtheir position in the market.

Increasing importance of patient-specific drug distribution system to minimize dosage errors led to the robust growth of the market. It is a convenient alternative over traditional methods and increases patient compliance & adherence during the treatment of various indications. They are proven reliable & safe and decrease the total cost of both manufacturing & treatment. Unit dose allows drug use monitoring and control misuse of medication during disease management. Further, unit dose offers greater adaptability with the automated process in dispensing and increase the efficiency. Along with this, changing regulations to control the dose errors have to lead to the rapid growth of the market. Healthcare systems considered unit dispensing as an essential part of drug distribution and increased opportunities for manufacturers. Other factors like changing socio-demographics and increasing awareness among the general population have created potential growth opportunities for manufacturers.

North America is a major shareholder in the global market due to high penetration among the general population. Europe is a second major shareholder in the global market due to supportive regulatory conditions. The the Asia Pacific & Latin America regions are expected to witness the highest growth rate due to a large number of the patient group and the high prevalence of the chronic disease. Latin America and Rest of world regions are expected to account a small share in the global market and expected to gain more traction during the forecast period due to increasing adoption.

Unit Drug Dose Delivery System market players include Mylan N.V., Amedra Pharmaceuticals LLC, Owen Mumford, Ypsomed AG, Antares Pharma, SHL Group, Johnson & Johnson and others

Unit Drug Dose Delivery System Market Segmentation :

By Region
•    North America
•    Europe
•    Asia Pacific
•    Latin America
•    Middle East and Africa

 By Material Type

• Plastic
• Polyethylene (PE)
• High Density Polyethylene (HDPE)
• Low Density Polyethylene (LDPE)
• oly Vinyl Chloride (PVC)P
• Polystyrene
• Polycarbonate
• Polypropylene
• Polyethylene Terephthalate (PET)
• Glass
• Type 1
• Type 2
• Type 3
• Others

By Product Type
•    Solid
•    Liquid
•    Powder

By End User
•    Hospitals
•    Clinics
•    Outpatient Centres

Signoficant Market Players:
•    Amcor Ltd.
•    Wipak Group
•    R-Pharm
•    Catalent Inc.
•    Piramal Glass Ltd.

Competitive Landscape:  

•    Tier 1 players- established companies in the market with a major market share
•    Tier 2 players 
•    Emerging players which are growing rapidly 
•    New Entrants  

FutureWise Key Takeaways 

•    Growth prospects
•    SWOT analysis 
•    Key trends 
•    Key data-points affecting market growth 

Objectives of the Study: 

•    To provide with an exhaustive analysis on the global Unit Drug Dose Delivery System Market by Product Type, by End-User, and by Region

•    To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
•    To evaluate and forecast micro-markets and the overall market 
•    To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East
•    To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
•    Profiling of companies to evaluate their market shares, strategies, financials and core competencies

Flexible Delivery Model:
•    We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
•    The customization Mobility Care offered are free of charge with purchase of any license of the report
•    You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
   1.1. Objectives of the Study 
   1.2. Market Definition 
   1.3. Market Scope 
        1.3.1. Years Considered for the Study
        1.3.2. Market Covered
   1.4. Currency 
   1.5. Limitations 
   1.6. Stakeholders 

2. Research Methodology 
   2.1. Research Data 
        2.1.1. Secondary Data
               2.1.1.1. Key Data from Secondary Sources
        2.1.2. Primary Data
               2.1.2.1. Key Data from Primary Sources
   2.2. Market Size Estimation 
   2.3. Market Breakdown and Data Triangulation 
   2.4. Assumptions for the Study  

3. Executive Summary
   3.1. Market Outlook
   3.2. Segment Outlook
   3.3. Competitive Insights

4. Unit Drug Dose Delivery System Market Variables, Trends & Scope
   4.1. Market Lineage Outlook
   4.2. Penetration and Growth Prospect Mapping
   4.3. Industry Value Chain Analysis
   4.4. Cost Analysis Breakdown
   4.5. Technology Overview
   4.6. Regulatory Framework
        4.6.1. Reimbursement Framework
        4.6.2. Standards and Compliances

5. Market Overview
   5.1. Market Dynamics
        5.1.1. Market Driver Analysis
               5.1.1.1. Increasing focus of Unit Drug Dose Delivery System Market Companies on Brand Protection
               5.1.1.2. Untapped Opportunities in Emerging Regions
        5.1.2. Market Restraint Analysis
               5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
        5.1.3. Industry Challenges
               5.1.3.1. Presence of Ambiguous Regulatory Framework

6. Unit Drug Dose Delivery System Market Analysis Tools
   6.1. Industry Analysis - Porter’s
        6.1.1. Supplier Power
        6.1.2. Buyer Power
        6.1.3. Substitution Threat
        6.1.4. Threat from New Entrants
        6.1.5. Competitive Rivalry
   6.2. Pestel Analysis
        6.2.1. Political Landscape
        6.2.2. Environmental Landscape
        6.2.3. Social Landscape
        6.2.4. Technology Landscape
        6.2.5. Legal Landscape
   6.3. Major Deals And Strategic Alliances Analysis
        6.3.1. Joint Ventures
        6.3.2. Mergers and Acquisitions
        6.3.3. Licensing and Partnership
        6.3.4. Technology Collaborations
        6.3.5. Strategic Divestments
   6.4. Market Entry Strategies
   6.5. Case Studies

7. Unit Drug Dose Delivery System Market, By Material Type Historical Analysis and Forecast 2022-2028 (USD Million)
   7.1. Plastic
        7.1.1. Polyethylene (PE)
               7.1.1.1. High Density Polyethylene (HDPE)
               7.1.1.2. Low Density Polyethylene (LDPE)
        7.1.2. oly Vinyl Chloride (PVC)P
        7.1.3. Polystyrene
        7.1.4. Polycarbonate
        7.1.5. Polypropylene
        7.1.6. Polyethylene Terephthalate (PET)
   7.2. Glass
        7.2.1. Type 1
        7.2.2. Type 2
        7.2.3. Type 3
        7.2.4. Others

8. Unit Drug Dose Delivery System Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million)  
   8.1. Solid
   8.2. Liquid
   8.3. Powder

9. Unit Drug Dose Delivery System Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million)  
   9.1. Hospitals
   9.2. Clinics
   9.3. Outpatient Centres

10. North America Unit Drug Dose Delivery System Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    10.1. Introduction
    10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          10.2.1. U.S.A
          10.2.2. Canada
          10.2.3. Mexico
    10.3. Market Size (USD Million) Forecast for North America 2022-2028

11. Latin America Unit Drug Dose Delivery System Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    11.1. Introduction
    11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          11.2.1. Brazil
          11.2.2. Venezuela
          11.2.3. Argentina
          11.2.4. Rest of Latin America
    11.3. Market Size (USD Million) Forecast for Latin America 2022-2028

12. Europe Unit Drug Dose Delivery System Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    12.1. Introduction
    12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          12.2.1. Germany
          12.2.2. U.K         
          12.2.3. France
          12.2.4. Italy
          12.2.5. Spain
          12.2.6. Russia
          12.2.7. Poland
          12.2.8. Rest of Europe
    12.3. Market Size (USD Million) Forecast for Europe 2022-2028

13. Asia Pacific Unit Drug Dose Delivery System Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    13.1. Introduction
    13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          13.2.1. Japan
          13.2.2. China
          13.2.3. India
          13.2.4. Australia and New Zealand
          13.2.5. ASEAN
          13.2.6. Rest of Asia Pacific
    13.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028  

14. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    14.1. Introduction
    14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          14.2.1. GCC
          14.2.2. Israel
          14.2.3. South Africa
          14.2.4. Rest of MEA
    14.3. Market Size (USD Million) Forecast for MEA 2022-2028

15. Market Share Analysis and Competitive Landscape   
    15.1. Global Landscape - Key Players, Revenue and Presence
    15.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
    15.3. Global Emerging Companies
    15.4. North America - Market Share Analysis and Key Regional Players
    15.5. Europe - Market Share Analysis and Key Regional Players
    15.6. Asia Pacific - Market Share Analysis and Key Regional Players
    15.7. Global Key Player - Growth Matrix

16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    16.1. Mylan N.V.
          16.1.1. Company Overview
          16.1.2. Product Portfolio
          16.1.3. SWOT Analysis
          16.1.4. Financial Overview
          16.1.5. Strategic Overview
    16.2. Amedra Pharmaceuticals LLC 
          16.2.1. Company Overview
          16.2.2. Product Portfolio
          16.2.3. SWOT Analysis
          16.2.4. Financial Overview
          16.2.5. Strategic Overview 
    16.3. Owen Mumford
          16.3.1. Company Overview
          16.3.2. Product Portfolio
          16.3.3. SWOT Analysis
          16.3.4. Financial Overview
          16.3.5. Strategic Overview
    16.4. Ypsomed AG
          16.4.1. Company Overview
          16.4.2. Product Portfolio
          16.4.3. SWOT Analysis
          16.4.4. Financial Overview
          16.4.5. Strategic Overview
    16.5. Antares Pharma
          16.5.1. Company Overview
          16.5.2. Product Portfolio
          16.5.3. SWOT Analysis
          16.5.4. Financial Overview
          16.5.5. Strategic Overview          
    16.6. SHL Group
          16.6.1. Company Overview
          16.6.2. Product Portfolio
          16.6.3. SWOT Analysis
          16.6.4. Financial Overview
          16.6.5. Strategic Overview     
    16.7. Johnson & Johnson
          16.7.1. Company Overview
          16.7.2. Product Portfolio
          16.7.3. SWOT Analysis
          16.7.4. Financial Overview
          16.7.5. Strategic Overview
   
17. Pre and Post COVID-19 Impact
    17.1. Positive influence on the healthcare industry
    17.2. The financial disruption of the manufacturing sector
    17.3. Impact of COVID-19 on emerging companies
    17.4. Significant mandates in the regulations initiated by healthcare administrations
    17.5. The overall economic slowdown of the developing and developed nations

18. FutureWise SME Key Takeaway Points for Client
 

Tables

Figures